Has Vision Eye got the eye from Primary Health Care Limited?

Primary ups its stake in Vision Eye to 21.88%

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It certainly appears so, with Primary Health Care Limited (ASX: PRY) announcing that it had upped its stake in Vision Eye FPO (ASX: VEI) from 20% to 21.884% earlier this week.

And you can certainly see the attraction. Vision Eye operates eye care clinics as well as 8 day surgeries and 7 refractive and laser surgery centres, which would be a nice addition to complement Primary's existing general medical, diagnostic imaging and pathology centres.

Vision operates what is known as a roll-up or aggregation model, where it acquires practices from ophamologists, then runs the business for them, leaving the specialist to focus on what they do best. It's a similar story to aggregators in various industries including the likes of dental – 1300 Smiles Limited (ASX: ONT), child care – G8 Education Limited (ASX: GEM), diagnostic imaging – Capitol Health Limited (ASX: CAJ), Primary Health Care itself and Sonic Healthcare Limited (ASX: SHL).

The model should have worked perfectly, but Vision Eye found that specialists were leaving after their initial contract terms, setting up new practices and taking their patients and respective revenues with them. After some years in the wilderness, Vision Eye appears to have found the solution with doctor numbers stabilising, and cashflows and profits improving.

But what appears to be a key focus of the company these days is the day surgery clinics and driving more revenue from those. Day surgeries could be leased out to other specialists rather than just eye specialists, driving utilisation rates higher.

Acquisitions have slowed as the company focuses on paying down its once-substantial debt pile, so Vision management appear to be driving more revenues and lowering costs at its existing facilities.

Primary may have taken an interest because it could easily pay off Vision's existing debt of less than $30 million, and roll out more specialist eye clinics at a faster rate.

Takeover provisions mean Primary can only purchase up to 3% of Vision every six months, once it has more than 20% of the shares, without making a takeover offer. But it only appears to be a matter of when, rather than if.

Motley Fool writer/analyst Mike King owns shares in Capitol Health and 1300 Smiles. You can follow Mike on Twitter @TMFKinga

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »